KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bionano Genomics (BNGO) Tax Provisions (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Tax Provisions for 9 consecutive years, with $35000.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 3400.0% to $35000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $66000.0 through Dec 2025, up 100.0% year-over-year, with the annual reading at $67000.0 for FY2025, 103.03% up from the prior year.
  • Tax Provisions hit $35000.0 in Q4 2025 for Bionano Genomics, up from $14000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $1.8 million in Q4 2022 to a low of -$5.8 million in Q4 2021.
  • Historically, Tax Provisions has averaged -$183650.0 across 5 years, with a median of $19000.0 in 2024.
  • Biggest five-year swings in Tax Provisions: plummeted 52327.27% in 2021 and later surged 3400.0% in 2025.
  • Year by year, Tax Provisions stood at -$5.8 million in 2021, then skyrocketed by 131.3% to $1.8 million in 2022, then crashed by 101.99% to -$36000.0 in 2023, then skyrocketed by 102.78% to $1000.0 in 2024, then soared by 3400.0% to $35000.0 in 2025.
  • Business Quant data shows Tax Provisions for BNGO at $35000.0 in Q4 2025, $14000.0 in Q3 2025, and $10000.0 in Q2 2025.